Wilding, John P.H.
University of Liverpool
66 papers on CoChatORCID 0000-0003-2839-8404
Most cited papers
- Verified
Impact of bariatric surgery on physical functioning in obese adults
Steele, T., Cuthbertson, D. J., & Wilding, J. P. H. (2015) · Obesity Reviews
Bariatric Surgery and OutcomesBody Contouring and Surgery
Cited by 62
- Verified
Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data.
Wharton, S., Astrup, A., Endahl, L., Lean, M. E. J., Satylganova, A., Skovgaard, D., Wadden, T. A., & Wilding, J. P. H. (2021) · International Journal of Obesity
Statistical Methods in Clinical TrialsStatistical Methods and Bayesian Inference
Cited by 58
- Verified
Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: a comprehensive economic evaluation using clinical trial and real-world evidence
McEwan, P., Bennett, H., Khunti, K., Wilding, J., Edmonds, C., Thuresson, M., Wittbrodt, E., Fenici, P., & Kosiborod, M. (2020) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life
Cited by 58
- Verified
Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome
Seetho, I. W., & Wilding, J. P. (2014) · Chronic Respiratory Disease
Obstructive Sleep Apnea ResearchSleep and related disorders
Cited by 57
- Verified · note
Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial
Zelniker, T. A., Raz, I., Mosenzon, O., Dwyer, J. P., Heerspink, H. H. J. L., Cahn, A., Goodrich, E. L., Im, K., Bhatt, D. L., Leiter, L. A., et al. (2021) · JAMA Cardiology
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 52
- Verified
Obesity pharmacotherapy in older adults: a narrative review of evidence
Henney, A. E., Wilding, J. P. H., Alam, U., & Cuthbertson, D. J. (2025) · International Journal of Obesity
Pharmacology and Obesity TreatmentNutrition and Health in Aging
Cited by 51
- Verified
Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study
Anson, M., Henney, A. E., Broadwell, N., Zhao, S. S., Ibarburu, G. H., Lip, G. Y. H., Wilding, J. P. H., Cuthbertson, D. J., & Alam, U. (2024) · eClinicalMedicine
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 44
- Verified
The double burden of malnutrition in individuals: Identifying key challenges and re‐thinking research focus
Kiosia, A., Dagbasi, A., Berkley, J. A., Wilding, J. P. H., Prendergast, A. J., Li, J. V., Swann, J., Mathers, J. C., Kerac, M., Morrison, D., et al. (2024) · Nutrition Bulletin
Obesity, Physical Activity, DietChild Nutrition and Water Access
Cited by 43
- Verified
Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial
Kushner, R. F., Ryan, D. H., Deanfield, J., Kokkinos, A., Cercato, C., Wilding, J., Burguera, B., Wu, C., Craciun, A., Pall, D., et al. (2025) · Obesity
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 35
- Verified
Should obesity be recognised as a disease?
Wilding, J. P. H., Mooney, V., & Pile, R. (2019) · BMJ
Obesity and Health PracticesObesity, Physical Activity, Diet
Cited by 34
- Verified
The cost-effectiveness of dapagliflozin in treating high-risk patients with type 2 diabetes mellitus: an economic evaluation using data from the DECLARE-TIMI 58 trial
McEwan, P., Morgan, A. R., Boyce, R., Bergenheim, K., Gause‐Nilsson, I. A. M., Bhatt, D. L., Leiter, L. A., Johansson, P. A., Mosenzon, O., Cahn, A., et al. (2021) · Diabetes, Obesity and Metabolism
Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and Management
Cited by 34
- Verified
Diazoxide choline extended‐release tablet in people with Prader‐Willi syndrome: results from long‐term open‐label study
Miller, J. L., Gevers, E., Bridges, N., Yanovski, J. A., Salehi, P., Obrynba, K. S., Felner, E. I., Bird, L. M., Shoemaker, A. H., Angulo, M., et al. (2024) · Obesity
Genetic Syndromes and ImprintingRegulation of Appetite and Obesity
Cited by 26
- Verified
Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance
Sadler, C. J., & Wilding, J. P. H. (2004) · Brain Research
Regulation of Appetite and ObesityHypothalamic control of reproductive hormones
Cited by 21
- Verified
Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes
Hydes, T. J., Summers, N., Brown, E., Alam, U., Thomaides‐Brears, H., Wilding, J. P. H., & Cuthbertson, D. J. (2020) · Diabetic Medicine
Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 21
- Verified
The Peripheral Neuropathy Prevalence and Characteristics Are Comparable in People with Obesity and Long-Duration Type 1 Diabetes
Lim, J. Z. M., Burgess, J., Ooi, C. G., Ponirakis, G., Malik, R. A., Wilding, J. P. H., & Alam, U. (2022) · Advances in Therapy
Peripheral Neuropathies and DisordersPain Mechanisms and Treatments
Cited by 19
- Verified
244-OR: Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial
RAZ, I., WIVIOTT, S. D., YANUV, I., ROZENBERG, A., ZELNIKER, T. A., CAHN, A., HEERSPINK, H. L., DWYER, J. P., GOODRICH, E., BHATT, D. L., et al. (2019) · Diabetes
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 15
- Verified
Why I eat at night: A qualitative exploration of the development, maintenance and consequences of Night Eating Syndrome
Shillito, J. A., Lea, J., Tierney, S., Cleator, J., Tai, S., & Wilding, J. P. H. (2018) · Appetite
Eating Disorders and BehaviorsNutrition, Health and Food Behavior
Cited by 11
- Verified
Age no Impediment to Effective Weight Loss with Liraglutide 3.0 Mg: Data from Two Randomized Trials
Rubino, D., Coelho, R., Kahan, S., Kushner, R., Wilding, J., Jepsen, C., Smolarz, G., & Wyatt, H. (2018) · International Journal of Nutrology
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free